EM
AGN

Excalibur Management’s Allergan plc AGN Stock Holding History

Excalibur Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-913
Closed -$222K – 79
2017
Q2 		$222K Hold
913
– – 0.2% 67
2017
Q1 		$218K Buy
+913
New +$213K 0.19% 68
2016
Q4 		– Sell
-913
Closed -$210K – 79
2016
Q3 		$210K Hold
913
– – 0.2% 65
2016
Q2 		$211K Hold
913
– – 0.18% 67
2016
Q1 		$245K Hold
913
– – 0.22% 61
2015
Q4 		$285K Hold
913
– – 0.27% 56
2015
Q3 		$248K Hold
913
– – 0.25% 52
2015
Q2 		$277K Hold
913
– – 0.26% 50
2015
Q1 		$272K Hold
913
– – 0.26% 48
2014
Q4 		$235K Hold
913
– – 0.24% 49
2014
Q3 		$220K Hold
913
– – 0.23% 53
2014
Q2 		$204K Buy
+913
New +$189K 0.21% 54

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Excalibur Management's AGN Position: Q3 2017 in Review

Excalibur Management sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 913 shares — an estimated $222K sold.

Excalibur Management first reported a position in AGN in Q2 2014 and held it in 12 quarters. The position peaked at $285K in Q4 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Excalibur Management reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Excalibur Management sold 913 Allergan plc shares in Q3 2017, an estimated $222K.
  • Excalibur Management first reported a position in Allergan plc in Q2 2014 and held it in 12 quarters.
  • Excalibur Management's Allergan plc position peaked at $285K in Q4 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Excalibur Management's 13F filing for Q3 2017, filed 25 Oct 2017.